Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors

Gill, Inderbir S.; Kavoussi, Louis R.; Lane, Brian R.; Blute, Michael L.; Babineau, Denise C.; Colombo, José R.; Frank, Igor; Permpongkosol, Sompol; Weight, Christopher J.; Kaouk, Jihad; Kattan, Michael W.; Novick, Andrew C.

doi:10.1016/j.juro.2007.03.038

Cited by 1,062 publications

(666 citation statements)

References 19 publications

Supporting

Mentioning

562

Contrasting

Unclassified

Order By: Relevance

“…SCRPN was first described in 2004 by Gettman et al [37]. Since then, SCRPN has been widely adopted in highvolume centers, especially in the United States [3].…”

Section: Kidney Cancermentioning

confidence: 99%

“…With the advent of LPN, Gill and his team analyzed data on 1,800 consecutive open or laparoscopic partial nephrectomies [37]. Gill et al discovered that LPN was highly associated with shorter operative time (P<0.0001), decreased operative blood loss (P<0.0001) and shorter hospital stay (P<0.001) [37].…”

Section: Oncological Outcomesmentioning

confidence: 99%

“…Gill et al discovered that LPN was highly associated with shorter operative time (P<0.0001), decreased operative blood loss (P<0.0001) and shorter hospital stay (P<0.001) [37]. As a result, Gill and his colleagues suggested that LPN was a viable alterative to traditional OPN [37].…”

Section: Oncological Outcomesmentioning

confidence: 99%

See 2 more Smart Citations

The Emergence of Surgeon-Controlled Robotic Surgery in Urologic Oncology

Patel

Babbar

Hemal

2011

Indian J Surg Oncol

View full text Add to dashboard Cite

The rise of robotic surgery is transforming medicine. In many ways, urology has taken charge in pioneering a new era of minimally invasive surgery with the emergence of the robot. The unprecedented dissecting precision and the dynamic three-dimensional, high definition view of the surgical field are undoubtedly revolutionizing the field of urology. These unique attributes of robotic surgery confer enormous advantages in dealing with urooncological surgery. The robotic revolution began nearly a decade ago with surgeon-controlled robotic radical prostatectomy and has since expanded to include radical cystectomies and partial nephrectomies. There have been numerous landmark studies published showing that robotic surgery provides comparable oncological and functional outcomes against traditional open or laparoscopic surgery. As a result, it becomes exceedingly imperative that urologists and the oncological community remain up-todate regarding these developments and appreciate the oncological outcomes of surgeon-controlled robotic surgery. This review will assess the impact surgeon-controlled robotic surgery has had in the field of urologic oncology.

show abstract

“…SCRPN was first described in 2004 by Gettman et al [37]. Since then, SCRPN has been widely adopted in highvolume centers, especially in the United States [3].…”

Section: Kidney Cancermentioning

confidence: 99%

Section: Oncological Outcomesmentioning

confidence: 99%

See 1 more Smart Citation

The Emergence of Surgeon-Controlled Robotic Surgery in Urologic Oncology

Patel

Babbar

Hemal

2011

Indian J Surg Oncol

View full text Add to dashboard Cite

show abstract

“…Las tasas de complicaciones peroperatorias y de preservación de la función de los riñones afectos (99,6% vs 97,9%) fueron similares entre las dos técnicas. Sin embargo, la NPL se asoció a mayor tiempo de isquemia caliente, mayor número de complicaciones postoperatorias (sobre todo urológicas) y a un mayor número de procedimientos para resolverlas 50 .…”

Section: Npl En Riñón úNicounclassified

Papel de la laparoscopia ante la masa renal menor de 4 cm

Briones

Zarranz

Escrig

2009

Actas Urológicas Españolas

View full text Add to dashboard Cite

N adie cuestiona en 2008 que la vía de elección para la exéresis de una glándula suprarrenal es la laparoscopia 1 . Tampoco se discute el cambio en la cirugía renal que ha supuesto la nefrectomía radical laparoscópica 2 . Por otro lado, todos estamos viviendo el incremento exponencial del diagnóstico de masas renales pequeñas (MRP) 3 , entendiendo éstas como aquellas menores de 4cm influenciados por el TNM y por la necesidad de un consenso en su definición. Original Papel de la laparoscopia ante la masa renal menor de 4 cmJosé Rubio Briones*, Javier Estébanez Zarranz**, J.L. Domínguez Escrig*** ResumenEl incremento en el diagnóstico incidental de masas renales pequeñas (MRP) -menores de 4cm-ha obligado a considerar tratamientos mínimamente invasivos para las mismas, sobre todo por el alto porcentaje de patologías no malignas indistinguibles de las tumorales radiológicamente. El acceso laparoscópico ha cobrado por tanto una importancia capital en el manejo de dichas masas, en un intento de disminuir la morbilidad de la lumbotomía.La nefrectomía parcial laparoscópica (NPL) es una técnica en evolución en la mayoría de centros que por un lado compite con la nefrectomía parcial abierta como técnica de elección y por otro lado competirá en un futuro con las técnicas no exeréticas. Estas también se han podido desarrollar de una manera más precisa gracias a la laparoscopia.En este artículo pretendemos, basándonos en una revisión estandarizada de la prolífica literatura a cerca del tratamiento de la MRP, revisar las innovaciones tecnológicas y las mejoras técnicas que la vía de abordaje laparoscópica nos va deparando, no solo como técnica exerética, sino como vehículo de tratamientos mínimamente invasivos, remarcando también los requerimientos de los Servicios de Urología y las mejoras que podrían hacerse en los sistemas sanitarios para que la NPL ganara terreno en el tratamiento de la MRP.La progresiva depuración de la técnica y la mejora del arsenal laparoscópico y de agentes hemostasiantes van a incrementar la indicación de NPL en un futuro. La escasa frecuencia de la patología y la necesidad de optimizar la técnica, obligarían a los responsables sanitarios a centralizar esta patología en centros con experiencia en laparoscopia y en nefrectomía parcial abierta. Role of laparoscopy in the presence of a renal mass under 4 cm in size AbstractThe increasingly common incidental diagnosis of small renal masses (SRMs)(measuring under 4 cm in size) has led to the consideration of applying minimally invasive techniques to deal with them -particularly in view of the high percentage of non-malignant conditions of this size that are radiologically indistinguishable from tumor lesions. Accordingly, laparoscopic access has gained great importance in the management of these masses, in an attempt to lessen the morbidity associated with lumbotomy.Laparoscopic partial nephrectomy (LPN) is an evolving technique in most centers; on one hand it competes with open partial nephrectomy as the technique of choice, and on the other it will c...

show abstract

“…Partial nephrectomy (PN) remains the gold standard for treatment of SRMs with oncological outcome comparable to radical nephrectomy but with better preservation of the renal function [4][5][6]. Laparoscopic partial nephrectomy, however, is technically more demanding with a steep learning curve and has a significant complication rate [7]. Robotic partial nephrectomy has made partial nephrectomy easier [8].…”

Section: Introductionmentioning

confidence: 99%

Non-Surgical Ablative Therapy for Management of Small Renal Masses—Current Status and Future Trends

Farrag

Sriprasad

2016

Indian J Surg Oncol

View full text Add to dashboard Cite

A large number of small renal masses (SRMs) with size less than 4 cm are being identified due to advances in diagnostic imaging. As the natural history of these tumours remains unknown, there is no reliable way to predict their behaviour or future growth. Although, partial nephrectomy is the gold standard for treatment of these tumours, ablative non-surgical therapies such as cryoablation and radiofrequency ablation provide a less invasive option of treatment with comparable oncological outcomes. In this systematic review, the principle, indications, methods of treatment, oncological control, complication and renal function of ablative therapies are critically reviewed. Cryotherapy utilizes the principle of inducing tissue destruction by freezing and thawing using argon and helium gasses, respectively. Radiofrequency ablation (RFA) works on the principle of tissue heating. Ablative treatments are particularly useful in the elderly patients, those with comorbidities or in patients with SRMs in solitary kidneys or renal impairment. Ablative therapies have less procedurerelated complications and have promising medium-term oncological outcome. Longer-term results are accumulating. Cryotherapy may be a better modality for oncological control than RFA. Ablative therapy has emerged as a viable treatment options for SRMs with recurrence free survival rates approaching that of extirpative surgery. However, there is no consensus in the literature on the best selection criteria and this needs further refinement. Prospective long-term data with regards to oncological control is still needed

show abstract

Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors

Cited by 1,062 publications

References 19 publications

The Emergence of Surgeon-Controlled Robotic Surgery in Urologic Oncology

The Emergence of Surgeon-Controlled Robotic Surgery in Urologic Oncology

Papel de la laparoscopia ante la masa renal menor de 4 cm

Non-Surgical Ablative Therapy for Management of Small Renal Masses—Current Status and Future Trends

Contact Info

Product

Resources

About